Holen Sie sich die Stockscreener-App
17.36
3.45%
-0.62
Handel nachbörslich:
17.37
0.01
+0.06%
Relay Therapeutics Inc Aktie (RLAY) Neueste Nachrichten
Form 4 Relay Therapeutics Inc For: 8 October By Investing.com - Investing.com Canada
Relay Therapeutics CFO Catinazzo sells $329k in shares - Investing.com
Relay Therapeutics CEO Sanjiv Patel sells $872,401 company stock - Investing.com
CEO sells 48,199 shares under a trading plan at Relay Therapeutics (RLAY). - Stock Titan
Under a trading plan, Relay Therapeutics (RLAY) CFO sells 17,511 shares plus 206 more. - Stock Titan
After two share sales, Sanjiv Patel proposes another at Relay Therapeutics (RLAY). - Stock Titan
After two 17,717-share sales, a Relay Therapeutics (RLAY) officer proposes another sale. - Stock Titan
Elevar Therapeutics Announces FDA Approval of Lyrfigtu (Lirafugratinib) as Second-line Cholangiocarcinoma with FGFR2 Fusion or Other Rearrangement Treatment Option - GlobeNewswire Inc.
Relay Therapeutics (Nasdaq:RLAY)Stock Analysis - simplywall.st
Relay Therapeutics CEO Sanjiv Patel sells 48,199 shares for $912,889.06 - Bitget
Relay Therapeutics (RLAY) Insider Sell: President, R&D Donald Be - GuruFocus
Relay Therapeutics R&D president sells $161,814 in stock By Investing.com - Investing.com South Africa
Relay Therapeutics R&D president sells $161,814 in stock By Investing.com - Investing.com Nigeria
Relay Therapeutics R&D president sells $161,814 in stock - Investing.com
Relay Therapeutics R&D president sells $161,814 in stock By Investing.com - Investing.com India
Relay Therapeutics R&D president sells $161,814 in stock By Investing.com - Investing.com Canada
Relay Therapeutics Insider Sold Shares Worth $912,889, According to a Recent SEC Filing - marketscreener.com
Relay Therapeutics (RLAY) R&D chief sells stock under 10b5-1 plan - Stock Titan
Relay Therapeutics (RLAY) CFO sells about $335K in stock under preset plan - Stock Titan
Relay Therapeutics (NASDAQ: RLAY) CEO sells shares under preset trading plan - Stock Titan
Relay Therapeutics Insider Sold Shares Worth $912,889, According to a Recent SEC Filing - Yahoo Finance
Relay Therapeutics at Wells Fargo conference: pipeline nears key tests By Investing.com - Investing.com Canada
Relay Therapeutics at Wells Fargo conference: pipeline nears key tests By Investing.com - Investing.com UK
Relay Therapeutics to Participate in Two Upcoming Investor Conferences in September - news.futunn.com
Relay Therapeutics CFO Sells 17,717 Shares for $350,000 - Yahoo Finance
Relay Therapeutics CFO Sells 17,717 Shares for $350,000 - The Motley Fool
Relay Therapeutics to Participate in Upcoming September Healthcare Conference Fireside Chats - Quiver Quantitative
Relay Therapeutics to Participate in Two Upcoming Investor Conferences in September - GlobeNewswire
Relay Therapeutics to Participate in Two Upcoming Investor Conferences in September - finance.yahoo.com
Relay Therapeutics management will join two live online talks this month - Stock Titan
Relay Therapeutics (RLAY) Insider Peter Rahmer Sells 4,508 Shares - GuruFocus
Relay Therapeutics (RLAY) exec sells 4,508 shares under plan - Stock Titan
SoftBank Vision Fund Subsidiary Sells 6 Million Shares of Relay Therapeutics at $19.4 Each - Kalkine Media
Relay Therapeutics director SVF Pauling (Cayman) sells $116.4m By Investing.com - Investing.com Canada
Relay Therapeutics director SVF Pauling (Cayman) sells $116.4m By Investing.com - Investing.com UK
Relay Therapeutics (NASDAQ: RLAY) 10% owner SoftBank sells 6M shares - Stock Titan
Relay Therapeutics director SVF Pauling (Cayman) sells $116.4m - Investing.com
Relay Therapeutics (NASDAQ: RLAY) officer eyes another stock sale after June trade - Stock Titan
Relay Therapeutics (NASDAQ: RLAY) holder plans sale of up to 6M shares - Stock Titan
What is HC Wainwright's Estimate for RLAY FY2027 Earnings? - MarketBeat
RLAY Maintained by HC Wainwright & Co. -- Price Target Raised to $29 - GuruFocus
Relay Therapeutics (NASDAQ:RLAY) Stock Price Expected to Rise, HC Wainwright Analyst Says - MarketBeat
H.C. Wainwright raises Relay Therapeutics price target to $29 By Investing.com - Investing.com Canada
Relay Therapeutics, Inc. $RLAY Shares Bought by Bank of America Corp DE - MarketBeat
Relay Therapeutics (RLAY) Reported Q2 Results, Is The Premium P B Multiple Justified? - Yahoo Finance
Relay Therapeutics (RLAY) Stock May Be Fully Valued After A 7x Run - simplywall.st
Timothy G. Youngquist 2020 Irrevocable Trust Boosts Stake in Relay Therapeutics, Inc. $RLAY - MarketBeat
Handelsbanken Fonder AB Buys New Shares in Relay Therapeutics, Inc. $RLAY - MarketBeat
Relay Therapeutics Insider Sold Shares Worth $979,886, According to a Recent SEC Filing - marketscreener.com
Relay Therapeutics (RLAY) CEO sells 48K shares in plan trade - Stock Titan
8.07%
0.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):